Disease-Modifying Treatments for Myasthenia Gravis | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Disease-Modifying Treatments for Myasthenia Gravis | stella

Back to Neurological Disorder trials

Completed

Plain-English translation of NCT03490539 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Read our Myasthenia gravis research guide →

Trial locations(19 sites)

United States

Stanford University, Palo Alto, California

Unversity of Miami, Miami, Florida

Rush University Medical Center, Chicago, Illinois

Ochsner Clinic Foundation, New Orleans, Louisiana

Massachusetts General Hospital, Boston, Massachusetts

Results

Read the full plain-English summary of this trial →

Key details

Sponsor

Duke University

Collaborators

Beth Israel Deaconess Medical Center, Patient-Centered Outcomes Research Institute

Enrollment target

~82 participants

Started

May 2018

Primary completion

January 2021

Age range

18 Years and older

Last updated on clinicaltrials.gov in June 2026.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov